Yamaguchi Shigeru, Terasaka Shunsuke, Kobayashi Hiroyuki, Narita Takuhito, Hirata Kenji, Shiga Satoshi, Usui Reiko, Tanaka Shinya, Kubota Kanako, Murata Junichi, Asaoka Katsuyuki
Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo, Japan.
No Shinkei Geka. 2010 Jul;38(7):621-8.
The aim of this study was to evaluate the usefulness of combined use of positron emission tomography (PET) with (18)F-fluorodeoxyglucose (FDG) and (11)C-methionine (MET) for the preoperative evaluation of gliomas and to investigate the feasibility of PET in glioma surgery.
Preoperative FDG (n=25) and/or MET (n=22) PET studies were performed in 26 patients with primary and recurrent adult gliomas. We qualitatively (visual analysis) and quantitatively evaluated the uptake of both tracers in the tumor location. For quantitative analysis, data were analyzed by a region of interest method using the standard uptake value (SUV) and a calculated uptake ratio. We investigated the correlation among the tracer uptake ratios, histological tumor grading and tumor proliferation activity.
On visual inspection, no patient (0/9) with high uptake of FDG had low grade gliomas and 94% (14/15) had high grade gliomas, while uptake of MET was present in all patients. On quantitative analysis, histological tumor grade was most reflected in FDG uptake ratio compared with contralateral white matter. The tumor/normal brain (T/N) uptake ratio of MET increased stepwise with increasing histological grade but was not significantly different from tumor grade. In comparison of FDG and MET uptake ratio with proliferation activity, a significant correlation was shown for FDG uptake ratio, but not for the T/N ratio of MET.
MET is useful in detecting and delineating the extent of the tumor, but not in evaluating tumor grade and proliferative activity. The FDG uptake ratio correlates well with tumor grade and proliferative activity. Preoperative PET studies with FDG and MET play complementary roles in the planning of glioma surgery, and integrated information from both tracers helps us to plan the extent of tumor resection.
本研究旨在评估正电子发射断层扫描(PET)联合(18)F-氟脱氧葡萄糖(FDG)和(11)C-蛋氨酸(MET)在胶质瘤术前评估中的应用价值,并探讨PET在胶质瘤手术中的可行性。
对26例原发性和复发性成人胶质瘤患者进行了术前FDG(n = 25)和/或MET(n = 22)PET研究。我们对两种示踪剂在肿瘤部位的摄取进行了定性(视觉分析)和定量评估。对于定量分析,采用感兴趣区法,使用标准摄取值(SUV)和计算得出的摄取率对数据进行分析。我们研究了示踪剂摄取率、组织学肿瘤分级和肿瘤增殖活性之间的相关性。
在视觉检查中,FDG摄取高的患者无一例(0/9)为低级别胶质瘤,94%(14/15)为高级别胶质瘤,而所有患者均有MET摄取。在定量分析中,与对侧白质相比,组织学肿瘤分级在FDG摄取率中反映最为明显。MET的肿瘤/正常脑(T/N)摄取率随组织学分级的增加而逐步升高,但与肿瘤分级无显著差异。在比较FDG和MET摄取率与增殖活性时,FDG摄取率显示出显著相关性,而MET的T/N比则无相关性。
MET有助于检测和勾勒肿瘤范围,但在评估肿瘤分级和增殖活性方面作用不大。FDG摄取率与肿瘤分级和增殖活性密切相关。术前FDG和MET的PET研究在胶质瘤手术规划中发挥着互补作用,两种示踪剂的综合信息有助于我们规划肿瘤切除范围。